newsfilter
← Latest News
GlobeNewswire·

Principia Updates PRN1008 Pemphigus Clinical Program

SOUTH SAN FRANCISCO, Calif., Dec. 30, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to...